All In Biotech

Free tool

FAERS Monitor: Betamethasone Dipropionate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019141 or its brand name (Betamethasone Dipropionate, Betamethasone Dipropionate). Reports on generic versions are filed under their own applications.

Reports

5,885

Serious

4,060

69% of reports

Hospitalization

1,812

Death reported

501

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,406
  • off label use641
  • macular degeneration532
  • nausea497
  • psoriasis466
  • pruritus454
  • pain450
  • condition aggravated410
  • pain in extremity392
  • headache390
  • fatigue379
  • rash375
  • dyspnoea340
  • product use in unapproved indication329
  • therapeutic product effect incomplete328

Reports by year received

View as table
YearReports
200417
200525
200618
200724
200822
200921
201016
201141
201250
201338
201448
201587
2016161
2017199
2018233
2019334
2020430
2021742
2022735
2023760
2024620
2025711
2026553

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,274 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
macular degenerationSignal532166.6153.383,541
therapeutic product effect incompleteSignal32816.614.94,771
psoriasisSignal46612.811.75,068
condition aggravatedSignal4104.84.41,256
pain in extremitySignal3924.84.31,175
product use in unapproved indicationSignal3294.74.3980
pruritusSignal4544.23.91,134
drug ineffectiveSignal1,4063.83.63,111
rashSignal3753.12.8534
painSignal4502.62.4462
off label useSignal6412.62.4666
nauseaSignal4972.22.1355
headacheSignal3902.22.0269
dyspnoeaSignal3402.11.9213
fatigue3791.71.6123

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.